Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US7357945B2 · kind B2 · utility
1Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2004 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Oct 1, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method. Preferably, the paroxetine hydrochloride is paroxetine hydrochloride hemihydrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.